Guiding Novel Neurologic Drug Approvals
The FDA’s review of drug and biological products in this medication class is critical, as a brain impairment impacts between 6.5% and 7.9% of adults in the United States.
Opioid Therapy–Associated Cardiovascular Effects
In patients taking prescribed opioids, an increased cardiovascular event rate has recently been reported in older adults..
Comparison of Chronic Pain and High-Impact Chronic Pain
The 2016 National Health Interview Survey found that high-impact chronic pain and chronic pain that does not limit major life activities were linked to various physical and mental conditions.
To Dose or Not to Dose?
Prescribing low-dose aspirin for preventing secondary cardiovascular disease is well established, but its safety and efficacy in primary prevention remains open to debate.
Copyright © 2000 - 2026 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.